iifl-logo

PGIM India Healthcare Fund Regular IDCW

PGIM India Healthcare Fund Regular IDCW

Fund Name

:  PGIM India Mutual Fund

Scheme Name

:  PGIM India Healthcare Fund Regular IDCW

AMC

:  PGIM India Mutual Fund

Type

:  Open

Category

:  Equity - Pharma

Launch Date

:  19-Nov-2024

Fund Manager

:  Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

:  125.15

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

PGIM India Healthcare Fund Regular IDCW - Nav Details

Nav Date

:  09-Oct-2026

NAV [Rs.]

:  11.64

Buy/Resale Price [Rs.]

:  0

Sell/Repurchase Price [Rs.]

:  0

Entry Load %

:  Nil

Exit Load %

:  For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Regular IDCW- NAV Chart

PGIM India Healthcare Fund Regular IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.93
-4.66
1.21
20
18.89
-
-
8.59
Category Avg
-1.98
-5.22
-0.65
16.08
12.34
19.94
13.57
14.8
Category Best
-1.21
-3.79
2.85
25.06
24.35
29.3
17.54
29
Category Worst
-2.68
-6.49
-4.69
4.89
-1.39
14.68
10.36
-6.4

PGIM India Healthcare Fund Regular IDCW- Latest Dividends

No Records Found

PGIM India Healthcare Fund Regular IDCW- Investment Details

Min. Investment(Rs.)

:  5000

Increm.Investment(Rs.)

:  1000

In & Out

In

InName Of The CompanyNo Of Shares
Symbiotec Pharma12,158
Molbio Diagnosti7,977

Out

InName Of The CompanyNo Of Shares
Pfizer5,665
Dr Agarwal's Hea20,940

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityDivi's Lab.Pharmaceuticals & Biotechnology10.361452913.49
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.257350813.35
EquityTorrent Pharma.Pharmaceuticals & Biotechnology8.492304611.06
EquityAjanta PharmaPharmaceuticals & Biotechnology4.96178556.46
EquityMax HealthcareHealthcare Services4.71660546.14
EquityDr Lal PathlabsHealthcare Services4.33284025.64
EquityMankind PharmaPharmaceuticals & Biotechnology4.04210455.26
EquityManipal HealthHealthcare Services3.68676464.79
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.2451224.22
EquityAbbott IndiaPharmaceuticals & Biotechnology3.1214984.06
EquityKrishna Institu.Healthcare Services2.99522473.89
EquityRubicon ResearchPharmaceuticals & Biotechnology2.99240703.89
EquityNeuland Labs.Pharmaceuticals & Biotechnology2.9117743.78
EquityAster DM QualityHealthcare Services2.56478913.33
EquitySai LifePharmaceuticals & Biotechnology2.54217563.31
EquityICICI LombardInsurance2.10172232.73
EquityCiplaPharmaceuticals & Biotechnology2.04197712.66
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.04228852.65
EquityLupinPharmaceuticals & Biotechnology1.93124002.51
EquityIpca Labs.Pharmaceuticals & Biotechnology1.92129902.50
EquityDr Agarwal's EyeHealthcare Services1.8647262.42
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.81274572.35
EquityGlobal HealthHealthcare Services1.52145511.98
EquityGland PharmaPharmaceuticals & Biotechnology1.5067251.94
EquityJupiter Life LinHealthcare Services1.46749501.90
EquityFortis Health.Healthcare Services1.46246401.89
EquitySymbiotec PharmaPharmaceuticals & Biotechnology1.10121581.43
EquityLenskart Solut.Retailing0.99187511.28
EquityMolbio DiagnostiHealthcare Equipment & Supplies0.8079771.04
EquityOrchid PharmaPharmaceuticals & Biotechnology0.79102851.02
EquitySagilityIT - Services0.401226240.52

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
27,858.82
Trustee/s:
PGIM India Trustees Priva
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Indrasena Yala Reddy, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Dr. V. R. Narasimham, Mr.Muralidharan Rajamani
Compliance Officer/s:
Mr. Sumesh Kumar, Mr. Sandeep Kamath
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
NA

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.